These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38963035)

  • 1. Improved efficacy of cisplatin delivery by peanut agglutinin‑modified liposomes in non‑small cell lung cancer.
    Yang B; Kou R; Wang H; Wang A; Wang L; Sun S; Shi M; Zhao S; Wang Y; Wang Y; Wu J; Wu F; Yang F; Qu M; Yu W; Gao Z
    Int J Mol Med; 2024 Aug; 54(2):. PubMed ID: 38963035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.
    Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X
    Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
    Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
    Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.
    Ren T; Shan J; Li M; Qing Y; Qian C; Wang G; Li Q; Lu G; Li C; Peng Y; Luo H; Zhang S; Yang Y; Cheng Y; Wang D; Zhou SF
    Drug Des Devel Ther; 2015; 9():2887-910. PubMed ID: 26089640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gefitinib encapsulation based on nano-liposomes for enhancing the curative effect of lung cancer.
    Hu Y; Zhang J; Hu H; Xu S; Xu L; Chen E
    Cell Cycle; 2020 Dec; 19(24):3581-3594. PubMed ID: 33300430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting Survivin.
    Tian H; Liu S; Zhang J; Zhang S; Cheng L; Li C; Zhang X; Dail L; Fan P; Dai L; Yan N; Wang R; Wei Y; Deng H
    J Biomed Nanotechnol; 2012 Aug; 8(4):633-41. PubMed ID: 22852473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multidrug resistance in human lung cancer cells by delivery of 3-octadecylcarbamoylacrylic acid-cisplatin-based liposomes.
    Song J; Ren W; Xu T; Zhang Y; Guo H; Zhu S; Yang L
    Drug Des Devel Ther; 2017; 11():441-449. PubMed ID: 28255230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and cytotoxicity of cisplatin-containing liposomes.
    Carvalho Júnior AD; Vieira FP; Melo VJ; Lopes MT; Silveira JN; Ramaldes GA; Garnier-Suillerot A; Pereira-Maia EC; Oliveira MC
    Braz J Med Biol Res; 2007 Aug; 40(8):1149-57. PubMed ID: 17665053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
    Tan S; Wang G
    Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer.
    Xiong Y; Zhao Y; Miao L; Lin CM; Huang L
    J Control Release; 2016 Dec; 244(Pt A):63-73. PubMed ID: 27840166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers.
    Song W; Li M; Tang Z; Li Q; Yang Y; Liu H; Duan T; Hong H; Chen X
    Macromol Biosci; 2012 Nov; 12(11):1514-23. PubMed ID: 23070837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells.
    Hirai M; Minematsu H; Hiramatsu Y; Kitagawa H; Otani T; Iwashita S; Kudoh T; Chen L; Li Y; Okada M; Salomon DS; Igarashi K; Chikuma M; Seno M
    Int J Pharm; 2010 May; 391(1-2):274-83. PubMed ID: 20211714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
    Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
    Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1.
    Wang Q; Wu J; Wei H; Huang H; Huang Y; Fang H; Gong X; Sun J; Wu Y; Lei C; Yu J; Hu D
    Int J Biochem Cell Biol; 2021 Sep; 138():106040. PubMed ID: 34246759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced toxicity of cisplatin with chemosensitizer phenethyl isothiocyanate toward non-small cell lung cancer cells when delivered in liposomal nanoparticles.
    Yang YT; Shi Y; Jay M; Di Pasqua AJ
    Chem Res Toxicol; 2014 Jun; 27(6):946-8. PubMed ID: 24836554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
    Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
    J Exp Clin Cancer Res; 2010 Jul; 29(1):87. PubMed ID: 20594324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma.
    Li X; Diao W; Xue H; Wu F; Wang W; Jiang B; Bai J; Lian B; Feng W; Sun T; Yu W; Wu J; Qu M; Wang Y; Gao Z
    Cancer Lett; 2020 Oct; 489():163-173. PubMed ID: 32592729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.